Cargando…
Generalization optimizing machine learning to improve CT scan radiomics and assess immune checkpoint inhibitors’ response in non-small cell lung cancer: a multicenter cohort study
BACKGROUND: Recent developments in artificial intelligence suggest that radiomics may represent a promising non-invasive biomarker to predict response to immune checkpoint inhibitors (ICIs). Nevertheless, validation of radiomics algorithms in independent cohorts remains a challenge due to variations...
Autores principales: | Tonneau, Marion, Phan, Kim, Manem, Venkata S. K., Low-Kam, Cecile, Dutil, Francis, Kazandjian, Suzanne, Vanderweyen, Davy, Panasci, Justin, Malo, Julie, Coulombe, François, Gagné, Andréanne, Elkrief, Arielle, Belkaïd, Wiam, Di Jorio, Lisa, Orain, Michele, Bouchard, Nicole, Muanza, Thierry, Rybicki, Frank J., Kafi, Kam, Huntsman, David, Joubert, Philippe, Chandelier, Florent, Routy, Bertrand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400292/ https://www.ncbi.nlm.nih.gov/pubmed/37546399 http://dx.doi.org/10.3389/fonc.2023.1196414 |
Ejemplares similares
-
Radiomics approaches to predict PD-L1 and PFS in advanced non-small cell lung patients treated with immunotherapy: a multi-institutional study
por: Yolchuyeva, Sevinj, et al.
Publicado: (2023) -
A Radiomics-Clinical Model Predicts Overall Survival of Non-Small Cell Lung Cancer Patients Treated with Immunotherapy: A Multicenter Study
por: Yolchuyeva, Sevinj, et al.
Publicado: (2023) -
Unravelling actionable biology using transcriptomic data to integrate mitotic index and Ki-67 in the management of lung neuroendocrine tumors
por: Manem, Venkata S.K., et al.
Publicado: (2021) -
Addendum: Unravelling actionable biology using transcriptomic data to integrate mitotic index and Ki-67 in the management of lung neuroendocrine tumors
por: Manem, Venkata S.K., et al.
Publicado: (2022) -
Helicobacter pylori serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitors
por: Tonneau, Marion, et al.
Publicado: (2022)